NDI-091143 is primarily utilized in the field of medical research, particularly in the study of cancer therapeutics. It functions as a potent and selective inhibitor of certain enzymes or proteins that are often overactive in cancer cells. Researchers employ this compound to investigate its effects on tumor growth and proliferation, aiming to develop targeted therapies that can inhibit cancer progression with minimal side effects. Its application extends to preclinical studies, where it is used to understand molecular pathways and validate potential drug targets. Additionally, NDI-091143 is valuable in screening assays to identify synergistic drug combinations, enhancing the efficacy of existing cancer treatments. Its role in advancing precision medicine makes it a critical tool in oncology research.